0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News & Perspectives |

FDA Warns Claims for Pharmacy-Made “Bio-identical” Hormones Are Misleading

Bridget M. Kuehn
JAMA. 2008;299(5):512. doi:10.1001/jama.299.5.512.
Text Size: A A A
Published online

Extract

The Food and Drug Administration (FDA) is warning physicians and consumers about false and misleading claims being made by some compounding pharmacies that are marketing so-called bio-identical hormone replacement therapy (BHRT) products. The agency also has sent warning letters to 7 such pharmacies; the warnings order the pharmacies to stop making these false or misleading claims and threaten further regulatory action if they do not comply.

Among the false or misleading claims the agency takes issue with are the description of these products as “bio-identical,” implying that these products are natural or identical to hormones made by the body. Additionally, the agency has warned the pharmacies to stop making unsupported claims. Such claims assert that these BHRT products are safer or more effective than FDA-approved hormone therapies and that they can treat or prevent conditions such as Alzheimer disease, stroke, heart disease, or cancers. The action was spurred by a petition from Wyeth in Madison, NJ, and physicians and consumer complaints.

Topics

hormone

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
CME Related by Topic
PubMed Articles
Jobs
brightcove.createExperiences();